Abtak Logo

bile-acid News

Stay updated with the latest bile-acid news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on bile-acid topics.

Unknown Source - Business - News Image
source image
BusinessAug 14, 2025 10:51 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

LatestLY - Business - News Image
soure image
14
BusinessAug 14, 2025 10:31 AM

Business News | Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide | ...

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >

News Nation English - Politics Business - News Image
soure image
30
PoliticsBusinessAug 14, 2025 10:20 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

ThePrint - Science Other Politics Environment Health Business Technology - News Image
soure image
5

Indian Institute of Science team creates glowing sensor for liver cancer detection | Bengaluru News ...

Bengaluru: Scientists from Indian Institute of Science (IISc) have developed a simple, glowing paper sensor that could help detect liver cancer early -- using the green glow of a rare earth metal called terbium.The sensor works by detecting an enzyme called "β-glucuronidase", which is found in many living organisms. While it has normal biological roles, high levels of this enzyme are linked to liver cancer, as well as colon, breast, and kidney cancers, and even infections and AIDS."Traditional d ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.